Literature DB >> 15469908

Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures.

Smitha Antony1, Paola B Arimondo, Jian-Sheng Sun, Yves Pommier.   

Abstract

Topoisomerase I (Top1) activities are sensitive to various endogenous base modifications, and anticancer drugs including the natural alkaloid camptothecin. Here, we show that triple helix-forming oligonucleotides (TFOs) can enhance Top1-mediated DNA cleavage by affecting either or both the nicking and the closing activities of Top1 depending on the position and the orientation of the triplex DNA structure relative to the Top1 site. TFO binding 1 bp downstream from the Top1 site enhances cleavage by inhibiting religation and to a lesser extent DNA nicking. In contrast, TFO binding 4 bp downstream from the Top1 site enhances DNA nicking especially when the 3' end of the TFO is proximal to the Top1 site. However, when the orientation of the triplex is inverted, with its 5' terminus 4 bp downstream from the Top1 site, religation is also inhibited. These position- and orientation-dependent effects of triplex structures on the Top1-mediated DNA cleavage and religation are discussed in the context of molecular modeling and effects of TFO on DNA twist and mobility at the duplex/triplex junction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469908      PMCID: PMC521660          DOI: 10.1093/nar/gkh847

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  52 in total

1.  Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages.

Authors:  Y Pommier; G Kohlhagen; P Pourquier; J M Sayer; H Kroth; D M Jerina
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  Stabilities of intrastrand pyrimidine motif DNA and RNA triple helices.

Authors:  P R Hoyne; A M Gacy; C T McMurray; L J Maher
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

Review 3.  Topoisomerase I-mediated DNA damage.

Authors:  P Pourquier; Y Pommier
Journal:  Adv Cancer Res       Date:  2001       Impact factor: 6.242

4.  Recombinogenic flap ligation pathway for intrinsic repair of topoisomerase IB-induced double-strand breaks.

Authors:  C Cheng; S Shuman
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

5.  Position-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]- pyrene diol epoxide adducts at the 6-amino group of adenine.

Authors:  Y Pommier; G S Laco; G Kohlhagen; J M Sayer; H Kroth; D M Jerina
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 6.  Triplex-forming molecules for modulation of DNA information processing.

Authors:  C Giovannangeli; C Hélène
Journal:  Curr Opin Mol Ther       Date:  2000-06

7.  Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures.

Authors:  M R Redinbo; L Stewart; J J Champoux; W G Hol
Journal:  J Mol Biol       Date:  1999-09-24       Impact factor: 5.469

8.  Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine.

Authors:  P Pourquier; L M Ueng; J Fertala; D Wang; H J Park; J M Essigmann; M A Bjornsti; Y Pommier
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

9.  Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA.

Authors:  M R Redinbo; J J Champoux; W G Hol
Journal:  Biochemistry       Date:  2000-06-13       Impact factor: 3.162

10.  Interaction of human DNA topoisomerase I with G-quartet structures.

Authors:  P B Arimondo; J F Riou; J L Mergny; J Tazi; J S Sun; T Garestier; C Hélène
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

View more
  6 in total

1.  The polypyrimidine/polypurine motif in the mouse mu opioid receptor gene promoter is a supercoiling-regulatory element.

Authors:  Chung-youl Choe; Hogyoung Kim; Jinping Dong; Andre J van Wijnen; Ping-Yee Law; Horace H Loh
Journal:  Gene       Date:  2011-07-31       Impact factor: 3.688

Review 2.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

Review 3.  Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).

Authors:  Yves Pommier; Shar-yin N Huang; Rui Gao; Benu Brata Das; Junko Murai; Christophe Marchand
Journal:  DNA Repair (Amst)       Date:  2014-05-22

4.  A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex.

Authors:  Christophe Marchand; Smitha Antony; Kurt W Kohn; Mark Cushman; Alexandra Ioanoviciu; Bart L Staker; Alex B Burgin; Lance Stewart; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2006-02       Impact factor: 6.261

5.  Bulge oligonucleotide as an inhibitory agent of bacterial topoisomerase I.

Authors:  Zhaoqi Yang; Tuoyu Jiang; Hanshi Zhong; Yu Kang
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 6.  Oligonucleotide-Recognizing Topoisomerase Inhibitors (OTIs): Precision Gene Editors for Neurodegenerative Diseases?

Authors:  Ben D Bax; Dmitry Sutormin; Neil Q McDonald; Glenn A Burley; Tatyana Shelkovnikova
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.